These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

314 related items for PubMed ID: 18595481

  • 1. The analysis of the correlation between extracellular fetal DNA concentration in maternal circulation and severity of preeclampsia.
    Engel K, Płonka T, Bilar M, Czajkowska E, Orzińska E, Brojer E, Ronin-Walknowska E.
    Ann Acad Med Stetin; 2007; 53(3):20-5. PubMed ID: 18595481
    [Abstract] [Full Text] [Related]

  • 2. The correlation between clinical characteristics of preeclampsia and the concentration of fetal DNA in maternal circulation.
    Engel K, Płonka T, Bilar M, Orzinska A, Brojer E, Ronin-Walknowska E.
    Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):256-7. PubMed ID: 17544562
    [No Abstract] [Full Text] [Related]

  • 3. Evaluation of maternal and umbilical serum TNFalpha levels in preeclamptic pregnancies in the intrauterine normal and growth-restricted fetus.
    Laskowska M, Leszczyńska-Gorzelak B, Laskowska K, Oleszczuk J.
    J Matern Fetal Neonatal Med; 2006 Jun; 19(6):347-51. PubMed ID: 16801311
    [Abstract] [Full Text] [Related]

  • 4. Quantification of cell free fetal DNA in maternal plasma in normal pregnancies and in pregnancies with placental dysfunction.
    Alberry MS, Maddocks DG, Hadi MA, Metawi H, Hunt LP, Abdel-Fattah SA, Avent ND, Soothill PW.
    Am J Obstet Gynecol; 2009 Jan; 200(1):98.e1-6. PubMed ID: 19121662
    [Abstract] [Full Text] [Related]

  • 5. Comparative analysis of the maternal and umbilical interleukin-8 levels in normal pregnancies and in pregnancies complicated by preeclampsia with intrauterine normal growth and intrauterine growth retardation.
    Laskowska M, Laskowska K, Leszczyńska-Gorzelak B, Oleszczuk J.
    J Matern Fetal Neonatal Med; 2007 Jul; 20(7):527-32. PubMed ID: 17674266
    [Abstract] [Full Text] [Related]

  • 6. Increased fetal DNA in the maternal circulation in early pregnancy is associated with an increased risk of preeclampsia.
    Cotter AM, Martin CM, O'leary JJ, Daly SF.
    Am J Obstet Gynecol; 2004 Aug; 191(2):515-20. PubMed ID: 15343229
    [Abstract] [Full Text] [Related]

  • 7. Association between tumor necrosis factor (TNF)-alpha G-308A gene polymorphism and preeclampsia complicated by severe fetal growth restriction.
    Molvarec A, Jermendy A, Nagy B, Kovács M, Várkonyi T, Hupuczi P, Prohászka Z, Rigó J.
    Clin Chim Acta; 2008 Jun; 392(1-2):52-7. PubMed ID: 18396154
    [Abstract] [Full Text] [Related]

  • 8. Assessment of the female fetal DNA concentration in the plasma of the pregnant women as preeclampsia indicator--preliminary report.
    Karina E, Tomasz P, Bilar M, Agnieszka O, Ewa B, Elzbieta RW.
    Eur J Obstet Gynecol Reprod Biol; 2009 Oct; 146(2):165-8. PubMed ID: 19632756
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Elevation of both maternal and fetal extracellular circulating deoxyribonucleic acid concentrations in the plasma of pregnant women with preeclampsia.
    Zhong XY, Laivuori H, Livingston JC, Ylikorkala O, Sibai BM, Holzgreve W, Hahn S.
    Am J Obstet Gynecol; 2001 Feb; 184(3):414-9. PubMed ID: 11228496
    [Abstract] [Full Text] [Related]

  • 11. sCD40 ligand determined in maternal and umbilical cord blood in pregnancies complicated by pre-eclampsia with and without intrauterine growth retardation.
    Laskowska M, Laskowska K, Leszczyńska-Gorzelak B, Oleszczuk J.
    Gynecol Obstet Invest; 2007 Feb; 64(1):8-13. PubMed ID: 17199090
    [Abstract] [Full Text] [Related]

  • 12. [Study on the relation between concentration of circulating non-host fetal DNA in pregnant women and pre-eclampsia].
    Tao H, Wang XM, Ji XH.
    Zhonghua Fu Chan Ke Za Zhi; 2005 Dec; 40(12):808-11. PubMed ID: 16412324
    [Abstract] [Full Text] [Related]

  • 13. Free fetal DNA is not increased before 20 weeks in intrauterine growth restriction or pre-eclampsia.
    Crowley A, Martin C, Fitzpatrick P, Sheils O, O'Herlihy C, O'Leary JJ, Byrne BM.
    Prenat Diagn; 2007 Feb; 27(2):174-9. PubMed ID: 17191257
    [Abstract] [Full Text] [Related]

  • 14. Elevated maternal levels of the long pentraxin 3 (PTX3) in preeclampsia and intrauterine growth restriction.
    Cetin I, Cozzi V, Pasqualini F, Nebuloni M, Garlanda C, Vago L, Pardi G, Mantovani A.
    Am J Obstet Gynecol; 2006 May; 194(5):1347-53. PubMed ID: 16647920
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. High maternal and fetal plasma urocortin levels in pregnancies complicated by hypertension.
    Florio P, Torricelli M, De Falco G, Leucci E, Giovannelli A, Gazzolo D, Severi FM, Bagnoli F, Leoncini L, Linton EA, Petraglia F.
    J Hypertens; 2006 Sep; 24(9):1831-40. PubMed ID: 16915033
    [Abstract] [Full Text] [Related]

  • 17. Increased free fetal DNA levels in early pregnancy plasma of women who subsequently develop preeclampsia and intrauterine growth restriction.
    Illanes S, Parra M, Serra R, Pino K, Figueroa-Diesel H, Romero C, Arraztoa JA, Michea L, Soothill PW.
    Prenat Diagn; 2009 Dec; 29(12):1118-22. PubMed ID: 19816882
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Maternal serum endostatin at gestational weeks 16-20 is elevated in subsequent pre-eclampsia but not in intrauterine growth retardation.
    Wathén KA, Ylikorkala O, Andersson S, Alfthan H, Stenman UH, Vuorela P.
    Acta Obstet Gynecol Scand; 2009 Dec; 88(5):593-8. PubMed ID: 19308751
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.